NCT07018934View on ClinicalTrials.gov

Alfuzosin and Mirabegron for Double-J Stent Symptoms

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 1, 2025

Conditions
Ureteral Stent-Related Symptoms
Trial Locations (1)

Unknown

Gaziantep University Faculty of Medicine Hospital, Gaziantep

All Listed Sponsors
lead

University of Gaziantep

OTHER

NCT07018934 - Alfuzosin and Mirabegron for Double-J Stent Symptoms | Biotech Hunter | Biotech Hunter